Erasca (ERAS) Shareholder's Equity Growth (1y) (2021 - 2026)
Erasca (ERAS) Shareholder's Equity Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Erasca |
4.28 Bn |
4.03 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-1.50% |
| Dec 31, 2025 |
-23.22% |
| Sep 30, 2025 |
-22.70% |
| Jun 30, 2025 |
-17.48% |
| Mar 31, 2025 |
38.52% |
| Dec 31, 2024 |
33.73% |
| Sep 30, 2024 |
32.77% |
| Jun 30, 2024 |
24.37% |
| Mar 31, 2024 |
-25.37% |
| Dec 31, 2023 |
-23.11% |
| Sep 30, 2023 |
-7.21% |
| Jun 30, 2023 |
-8.19% |
| Mar 31, 2023 |
-9.00% |
| Dec 31, 2022 |
-9.79% |
| Sep 30, 2022 |
-24.36% |
| Jun 30, 2022 |
363.38% |
| Mar 31, 2022 |
428.54% |
| Dec 31, 2021 |
500.52% |
| Sep 30, 2021 |
1,014.36% |
| Jun 30, 2021 |
-252.49% |
